reglab/housing_qa huggingface dataset:
IN Code § 16-41-43-2.3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-2.3. Dispensing and Administration of Auto-Injectable Epinephrine; Statewide Standing Order

Sec. 2.3. (a) A pharmacist may, by standing order, dispense auto-injectable epinephrine without examining the individual to whom it may be administered if all of the following conditions are met:(1) The auto-injectable epinephrine is dispensed to a person who:(A) presents a certificate of completion issued under section 2.5(c) of this chapter to the pharmacist before the auto-injectable epinephrine is dispensed; and(B) is an individual who is or may be in a position to assist an individual who is at risk of experiencing anaphylaxis.(2) The pharmacist provides instruction concerning how to properly administer auto-injectable epinephrine from the specific device being dispensed at the time of the device's dispensing.(3) The pharmacist instructs the individual receiving the auto-injectable epinephrine to summon emergency medical services either immediately before or immediately after administering the auto-injectable epinephrine to an individual experiencing anaphylaxis.(b) A person wishing to receive auto-injectable epinephrine by standing order must do the following:(1) Successfully complete the course described in section 2.5(a) of this chapter.(2) Present a certificate of completion issued under section 2.5(c) of this chapter to a pharmacist at the time the auto-injectable epinephrine is requested.(c) An individual described in subsection (a)(1) may administer auto-injectable epinephrine to an individual that the person reasonably believes is experiencing anaphylaxis.(d) An individual described in subsection (a)(1) may not be considered to be practicing medicine without a license in violation of IC 25-22.5-8-2 if the individual, acting in good faith:(1) obtains auto-injectable epinephrine from a pharmacist by standing order;(2) administers auto-injectable epinephrine to an individual that the person reasonably believes is experiencing anaphylaxis in a manner that is consistent with:(A) the training provided during the course described in section 2.5(a) of this chapter; or(B) the instruction provided to the person by a pharmacist at the time the auto-injectable epinephrine was dispensed; and(3) attempts to summon emergency medical services either immediately before or immediately after administering the auto-injectable epinephrine.(e) The state department shall ensure that a statewide standing order for the dispensing of auto-injectable epinephrine in Indiana is issued under this section. The state health commissioner may, as part of the individual's official capacity, issue a statewide standing order that may be used for the dispensing of auto-injectable epinephrine under this section. The immunity provided in IC 34-13-3-3 applies to an individual described in this subsection.As added by P.L.114-2020, SEC.4.
IN Code § 16-41-43-2.5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-2.5. Department Approval of Courses on Auto-Injectable Epinephrine; Certificate of Completion; Rules

Sec. 2.5. (a) The state department shall approve courses concerning allergies and the administration of auto-injectable epinephrine that are offered by an approved organization (as defined in IC 25-1-4-0.2).(b) The state department shall do the following:(1) Maintain, on its Internet web site, a list of all approved courses.(2) Prescribe the certification process for the course described in subsection (a).(3) Revoke the certification of an organization that fails to comply with any certification prerequisite specified by the state department.(c) A person who successfully completes a certified course shall receive a certificate of completion. The state department may contract with a third party for the purpose of creating or manufacturing the certificate of completion, which must meet the requirements set forth in subsection (d).(d) A certificate of completion issued under subsection (c) must:(1) have dimensions that permit the certificate of completion to be carried in a wallet; and(2) display the following information:(A) The first and last name of the person.(B) The first and last name of the course instructor.(C) The name of the entity responsible for providing the course, if applicable.(D) The date the course described in subsection (a) was completed.(E) Any other information required by the state department.(e) The state department may adopt rules under IC 4-22-2, including emergency rules under IC 4-22-2-37.1, to implement this section.As added by P.L.114-2020, SEC.5.
IN Code § 16-41-43-3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-3. Prescription for Auto-Injectable Epinephrine; Storage

Sec. 3. (a) An entity may fill a prescription for auto-injectable epinephrine and store the auto-injectable epinephrine on the premises of the entity if a health care provider who is licensed in Indiana and whose scope of practice includes the prescribing of medication writes or electronically transmits the prescription for auto-injectable epinephrine for the entity.(b) The entity shall store the auto-injectable epinephrine in a safe location in which only the entity's personnel or agents have access.As added by P.L.59-2015, SEC.2. Amended by P.L.28-2019, SEC.1.
IN Code § 16-41-43-3.5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-3.5. Expiration Date Requirement

Sec. 3.5. Injectable epinephrine that is filled and used in accordance with this chapter must have an expiration date of not less than twelve (12) months from the date that the pharmacy dispenses the injectable epinephrine to the entity or person, as applicable.As added by P.L.117-2017, SEC.2. Amended by P.L.114-2020, SEC.6.
IN Code § 16-41-43-4 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-4. Administration of Auto-Injectable Epinephrine; Employees and Agents; Training

Sec. 4. (a) A nurse employed by an entity may administer auto-injectable epinephrine obtained under section 3 of this chapter to any of the following individuals if the individual is demonstrating signs or symptoms of life threatening anaphylaxis and the individual does not have epinephrine at the entity or the individual's prescription is not available:(1) Employees or agents of the entity.(2) Visitors at the entity.(b) An entity's employees and agents may administer auto-injectable epinephrine obtained under section 3 of this chapter if the following are met:(1) The entity employee or agent has voluntarily received training in:(A) recognizing anaphylaxis; and(B) the proper administration of auto-injectable epinephrine;by a health care provider who is licensed or certified in Indiana, for whom the administration of auto-injectable epinephrine is within the health care provider's scope of practice, who has received training in the administration of auto-injectable epinephrine, and who is knowledgeable in recognizing the symptoms of anaphylaxis and the administration of auto-injectable epinephrine.(2) The individual to whom the epinephrine is being administered is:(A) an employee or agent of the entity; or(B) a visitor at the entity.As added by P.L.59-2015, SEC.2.
IN Code § 16-41-43-5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-5. Prescribing of Auto-Injectable Epinephrine; Dispensing

Sec. 5. (a) A health care provider who is licensed in Indiana and whose scope of practice includes the prescribing of medication may write or electronically transmit a prescription, drug order, or protocol for auto-injectable epinephrine for the entity.(b) A pharmacist licensed under IC 25-26 may dispense a valid prescription, drug order, or protocol for auto-injectable epinephrine issued in the name of an entity.As added by P.L.59-2015, SEC.2. Amended by P.L.28-2019, SEC.2.
IN Code § 16-41-43-5.5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-5.5. Immunity From Civil Liability in Connection With Administration of Auto-Injectable Epinephrine

Sec. 5.5. (a) This chapter does not apply to a person who is eligible for immunity specified in one (1) or more of the following sections:(1) Section 6 of this chapter.(2) IC 20-34-4.5-4.(3) IC 21-44.5-2-6.(b) Except as provided in subsection (d), a person who meets all of the following criteria is not liable for civil damages for any act or omission related to the administration of auto-injectable epinephrine:(1) The person has successfully completed a course described in section 2.5(a) of this chapter before administering auto-injectable epinephrine to a person.(2) The person administered the auto-injectable epinephrine in a manner that was consistent with:(A) the training provided during the course described in section 2.5(a) of this chapter; or(B) the instruction provided to the person by the pharmacist at the time the auto-injectable epinephrine was dispensed to the person.(3) The person reasonably believed that the recipient of the auto-injectable epinephrine was suffering from anaphylaxis at the time the auto-injectable epinephrine was administered.(c) A pharmacist who complies with section 2.3(a) of this chapter is not liable for civil damages resulting from the administration of auto-injectable epinephrine.(d) The immunity described in subsection (b) or (c) does not apply to any act or omission that constitutes gross negligence or willful and wanton misconduct.As added by P.L.114-2020, SEC.7.
IN Code § 16-41-43-6 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 43. Auto-Injectable Epinephrine|16-41-43-6. Civil Immunity

Sec. 6. (a) A nurse employed by an entity or an employee of the entity who administers auto-injectable epinephrine in accordance with the manufacturer's guidelines and with this chapter is not liable for civil damages resulting from the administration of auto-injectable epinephrine under this chapter unless the act or omission constitutes gross negligence or willful or wanton misconduct.(b) A licensed health care provider who:(1) writes a prescription, drug order, or protocol under this chapter;(2) transmits in an electronic format a prescription, drug order, or protocol for an electronically transmitted prescription under this chapter; or(3) provides training to an entity's personnel under this chapter;is not liable for civil damages resulting from the administration of auto-injectable epinephrine under this chapter.As added by P.L.59-2015, SEC.2. Amended by P.L.28-2019, SEC.3.
IN Code § 16-42-1-1 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-1. Purpose of Act

Sec. 1. (a) IC 16-42-1 through IC 16-42-4 are intended to safeguard the public health and promote the public welfare by protecting the:(1) consuming public from injury by product use; and(2) purchasing public from injury by merchandising deceit;flowing from intrastate commerce in food, drugs, devices, and cosmetics.(b) IC 16-42-1 through IC 16-42-4 are intended to be uniform with the:(1) Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), as amended by the FDA Food Safety Modernization Act (Public Law 111-353); and(2) Federal Trade Commission Act (15 U.S.C. 41 et seq.);including amendments to those statutes, to the extent they expressly outlaw the false advertisement of food, drugs, devices, and cosmetics.(c) IC 16-42-1 through IC 16-42-4 thus promote uniformity of such statutes and their administration and enforcement throughout the United States.[Pre-1993 Recodification Citation: 16-1-28-2(a), (b).]As added by P.L.2-1993, SEC.25. Amended by P.L.101-2018, SEC.3.
IN Code § 16-42-1-1.1 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-1.1. Duties of State Veterinarian and State Board of Animal Health

Sec. 1.1. (a) The state veterinarian shall act in place of the state health commissioner under this chapter when impounding or disposing of adulterated or misbranded products under IC 15-17-5 or IC 15-18-1.(b) The Indiana state board of animal health shall act in place of the state department of health under this chapter when impounding or disposing of adulterated or misbranded products under IC 15-17-5 or IC 15-18-1.As added by P.L.137-1996, SEC.68. Amended by P.L.2-2008, SEC.41.
IN Code § 16-42-1-2 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-2. Authority to Adopt Certain Federal Regulations

Sec. 2. The purpose of IC 16-42-1 through IC 16-42-4 being to promote uniformity with the Federal Act, in safeguarding the public health and in promoting public welfare, the state department may adopt, insofar as applicable, the regulations promulgated under the Federal Act and the Fair Packaging and Labeling Act (15 U.S.C. 1451 et seq.).[Pre-1993 Recodification Citation: 16-1-28-8.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-3 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-3. Adoption of Regulations; Notice and Hearing

Sec. 3. Except to the extent that the state department adopts the applicable regulations promulgated by the federal security administrator under the Federal Act (21 U.S.C. 301 et seq.), the state department, before adopting a rule contemplated by section 6 or 9 of this chapter, IC 16-42-2-1, IC 16-42-2-3(11), IC 16-42-3-4(4), IC 16-42-3-4(6), IC 16-42-3-4(7), or IC 16-42-3-4(8) shall give appropriate notice of the proposal and of the time and place for a public hearing to be held as provided by law.[Pre-1993 Recodification Citation: 16-1-28-9.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-4 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-4. Construction of Act and Rules

Sec. 4. IC 16-42-1 through IC 16-42-4 and rules adopted under those provisions shall, insofar as applicable, be interpreted and construed to effectuate the general purpose to enact state legislation uniform with the Federal Act (21 U.S.C. 301 et seq.).[Pre-1993 Recodification Citation: 16-1-28-16.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-5 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-5. Federal Agency References; Successor Agency

Sec. 5. Whenever this chapter refers to a department or an agency of the federal government, the term includes a department or an agency of the federal government to which the duties, powers, or functions are transferred or given.[Pre-1993 Recodification Citation: 16-1-28-3(a) part.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-6 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-6. Registration of Manufacturer, Processor, Repackager, or Wholesale Distributor; Maintaining Place of Business in State

Sec. 6. (a) A manufacturer, processor, repackager, or wholesale distributor of food, drugs, or cosmetics who maintains a place of business in Indiana shall file with the state department, upon forms to be furnished by the state department, a written statement of the name and address of the owner, the character of the business, and the business address of each place of business in Indiana.(b) A new place of business for the manufacture, processing, repacking, or wholesale distribution of food, drugs, or cosmetics may not be established in Indiana until the place of business has been registered as provided in this chapter.(c) If ownership of a registered place of business changes, the new owner shall reregister the place of business before operating the same.[Pre-1993 Recodification Citation: 16-1-29-15.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-7 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-7. Misleading Advertising or Labeling; Evaluation of Representations

Sec. 7. If:(1) an article is alleged to be misbranded because the labeling is misleading; or(2) an advertisement is alleged to be false because the advertisement is misleading;in determining whether the labeling or advertisement is misleading, there shall be taken into account among other items not only representations made or suggested by statement, word, design, device, sound, or any combination of those methods, but also the extent to which the labeling or advertisement fails to reveal facts that are material in the light of representations or that are material with respect to consequences that may result from the use of the article to which the labeling or advertisement relates under the conditions of use prescribed in the labeling or advertisement or under conditions of use that are customary or usual.[Pre-1993 Recodification Citation: 16-1-28-3(l) part.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-8 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-8. Labeling Requirements; Visibility

Sec. 8. A labeling requirement under IC 16-42-1 through IC 16-42-4 is not considered to be complied with unless:(1) the word, statement, or other information appearing on the label also appears on the outside container or wrapper, if any, of the retail package of the article; or(2) the word, statement, or other information appearing on the label is easily seen through the outside container or wrapper.[Pre-1993 Recodification Citation: 16-1-28-3(i) part.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-9 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-9. Advertisements; Curative or Therapeutic Effect for Certain Diseases

Sec. 9. (a) This section does not apply to an advertisement that:(1) is disseminated only to members of the medical, dental, pharmaceutical, and other legally recognized professions dealing with the healing arts;(2) appears only in the scientific periodicals of those professions; or(3) is disseminated only for the purpose of public health education by persons not commercially interested in the sale of such drugs or devices.(b) The advertisement of a drug or device that represents that the drug or device has any effect in:albuminuriaappendicitisarteriosclerosisblood poisonbone diseaseBright's diseasecarbunclescancercholecystitisdiabetesdiphtheriadropsyerysipelasgallstonesheart and vascular diseaseshigh blood pressuremastoiditismeaslesmumpsnephritisotitis mediaparalysispneumoniapoliomyelitis (infantile paralysis)prostate gland disorderspyelitisscarlet feversexual impotencesinus infectionsmallpoxtuberculosistumorstyphoiduremiavenereal diseasemeningitisis considered false for purposes of IC 35-43-5-4.(c) Whenever the state department determines that an advance in medical science has made a type of self medication safe as to any of the diseases listed in this section, the state department shall adopt rules to authorize the advertisement of drugs having curative or therapeutic effect for the disease, subject to conditions and restrictions the state department considers necessary in the interests of public health.[Pre-1993 Recodification Citation: 16-1-28-7.]As added by P.L.2-1993, SEC.25. Amended by P.L.174-2021, SEC.17.
IN Code § 16-42-1-10 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-10. Samples or Specimen; Investigation and Examination

Sec. 10. The state department shall cause the investigation and examination of food, drugs, devices, and cosmetics subject to IC 16-42-1 through IC 16-42-4. The state health commissioner or the commissioner's authorized representative may do the following:(1) Take a sample or specimen of any such merchandise, for examination under IC 16-42-1 through IC 16-42-4, upon tendering the market price to the person having the merchandise in custody.(2) Enter any place, establishment, or vehicle in Indiana at reasonable times for the purpose of taking a sample or specimen of merchandise for examination.[Pre-1993 Recodification Citation: 16-1-28-10.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-11 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-11. Inspection of Records

Sec. 11. For the purpose of enforcing IC 16-42-1 through IC 16-42-4, pertinent records of an administrative agency of the state are open to inspection by the state health commissioner or the commissioner's authorized representative.[Pre-1993 Recodification Citation: 16-1-28-11.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-12 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-12. Access to and Copying of Records; Use of Evidence

Sec. 12. (a) For the purpose of enforcing IC 16-42-1 through IC 16-42-4, carriers engaged in commerce, and persons receiving food, drugs, devices, or cosmetics in commerce or holding such articles so received shall, upon the request of an officer or employee designated by the state department, permit the officer or employee, at reasonable times, to have access to and to copy all records showing the movement in commerce of any food, drug, device, or cosmetic, or the holding of a food, drug, device, or cosmetic during or after the movement, and the quantity, shipper, and consignee of the food, drug, device, or cosmetic.(b) It is unlawful for a carrier or person described in subsection (a) to fail to permit access to and copying of such records upon request if the request is accompanied by a statement in writing specifying the nature or kind of food, drug, device, or cosmetic to which the request relates.(c) Evidence obtained under this section may not be used in a criminal prosecution of the person from whom the evidence is obtained.[Pre-1993 Recodification Citation: 16-1-28-12.]As added by P.L.2-1993, SEC.25.
IN Code § 16-42-1-13 (2021)
2021 Indiana Code|Title 16. Health|Article 42. Regulation of Food, Drugs, and Cosmetics|Chapter 1. Uniform Food, Drug, and Cosmetic Act: General Provisions|16-42-1-13. Entry and Inspections

Sec. 13. For the purpose of enforcing IC 16-42-1 through IC 16-42-4, the state health commissioner or the commissioner's authorized representative may do the following:(1) Enter, at reasonable times any produce farm, factory, warehouse, place of production, or establishment subject to IC 16-42-1 through IC 16-42-4 or enter any vehicle being used to transport or hold food, drugs, devices, or cosmetics.(2) Inspect, at reasonable times, the produce farm, factory, warehouse, place of production, establishment, or vehicle and all pertinent equipment, finished and unfinished materials, containers, labeling, and advertisements.[Pre-1993 Recodification Citation: 16-1-28-13.]As added by P.L.2-1993, SEC.25. Amended by P.L.101-2018, SEC.4.